EMERGENT BIOSOLUTIONS PLANNED SPIN-OFF

Posted By: Yinon Arieli April 16, 2016

EMERGENT BIOSOLUTIONS ANNOUNCES FILING OF FORM 10 REGISTRATION STATEMENT FOR ITS PLANNED SPIN-OFF OF ITS BIOSCIENCES BUSINESS APTEVO THERAPEUTICS EBS.N. Read more…

	This Year	Yearly Average
Long Run Plan	-1.5%	20.4%
S&P 500	-1.9%	11.2%
Updated: 2025-03-09
Portfolio Inception: Feb-2004
English Version: Jan-2016

The Long Run Plan

Value Investing Stock Ideas and Screeners

EMERGENT BIOSOLUTIONS PLANNED SPIN-OFF

Be the first to comment on "EMERGENT BIOSOLUTIONS PLANNED SPIN-OFF"

Leave a comment Cancel reply